Fundraising Fox
Krystal Biotech
Pittsburgh, US · Founded 2017 · 3 known investors
Find your way into Krystal Biotech
Sign up to see every warm intro you have to Krystal Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Krystal Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions. The company operates across the US, Europe, and Japan.
Founders & leadership
Krystal Biotech was founded in 2017 by Suma Krishnan and Krish Krishnan.
DN
Doug NorbyNamed on SEC filing
DR
Dino RossiNamed on SEC filing
Board
DJ
Investors · 3
Avoro Capital Advisorslisted by Avoro Capital AdvisorsNew York
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.3M disclosed across 1 round · 2017
▶$11.3MraisedAug 2017 · 16 investors · BiotechnologyRule 506(b)
▶$11.3MraisedAug 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug NorbyDirector
- Dan JanneyDirector
- Dino RossiDirector
- Suma M. KrishnanDirector
- Krish S. KrishnanExecutive Officer, Director
- Offering amount
- $11.3M
- Amount sold
- $11.3M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
InvenInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.
Aro BiotherapeuticsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Companies working in the same space as Krystal Biotech.
Frequently asked questions
- What does Krystal Biotech do?
- Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions. The company operates across the US, Europe, and Japan.
- Who founded Krystal Biotech?
- Krystal Biotech was founded by Suma Krishnan, Krish Krishnan in 2017.
- Who are Krystal Biotech's investors?
- Krystal Biotech's investors include Avoro Capital Advisors, Frazier Life Sciences, Alta Partners.
- How much funding has Krystal Biotech raised?
- Krystal Biotech has disclosed $11.3M raised across 1 round.
- Where is Krystal Biotech headquartered?
- Krystal Biotech is headquartered in Pittsburgh, US.